HutchMED (China) LIMITED Net Income (Loss) Attributable to Noncontrolling Interest
HutchMED (China) LIMITED (HCM) reported Net Income (Loss) Attributable to Noncontrolling Interest of $823.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-03-05
- HutchMED (China) LIMITED net income (loss) attributable to noncontrolling interest for the quarter ending 2019-12-31 was $574.00K, a 27.16% decline year-over-year.
- HutchMED (China) LIMITED net income (loss) attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$143.00K, a 186.67% decline year-over-year.
- HutchMED (China) LIMITED net income (loss) attributable to noncontrolling interest for the quarter ending 2019-06-30 was $1.14M, a 8.54% decline year-over-year.
- HutchMED (China) LIMITED net income (loss) attributable to noncontrolling interest for the quarter ending 2019-03-31 was $779.00K, a 41.21% decline year-over-year.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $823.00K 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $601.00K 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $441.00K 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $364.00K 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $314.00K 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $917.00K 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $449.00K 20-F · filed 2025-03-19 | |||
| 2022-06-30 | -$11.00K 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $27.61M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $3.06M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $10.21M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $1.45M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $574.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $431.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.57M derived: sum of 3 quarters · filed 2022-03-03 | $2.35M 20-F · filed 2022-03-03 |
| 2019-09-30 | -$143.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $992.00K derived: sum of 2 quarters · filed 2020-07-30 | $1.77M 6-K · filed 2020-01-21 | $2.56M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $1.14M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $1.91M 6-K · filed 2020-07-30 | $2.70M derived: sum of 3 quarters · filed 2021-03-04 | $2.87M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $779.00K 6-K · filed 2019-06-06 | $1.57M derived: sum of 2 quarters · filed 2021-03-04 | $1.73M derived: sum of 3 quarters · filed 2021-03-04 | $2.97M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $788.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $953.00K derived: sum of 2 quarters · filed 2021-03-04 | $2.19M derived: sum of 3 quarters · filed 2021-03-04 | $3.52M 20-F · filed 2021-03-04 |
| 2018-09-30 | $165.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $1.41M derived: sum of 2 quarters · filed 2020-01-21 | $2.73M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $1.24M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $2.57M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $1.32M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $3.77M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $2.00M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $2.86M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $2.26M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $2.43M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $3.22M 20-F · filed 2017-03-13 |